Skip to content

Korea
World
Technology
Business
Sports
Entertainment
Health

Korea
World
Technology
Business
Sports
Entertainment
Health

Yuhan

Yuhan Corporation became the 31st Korean drug for lung cancer treatment

Yuhan Corporation became the 31st Korean drug for lung cancer treatment

Acquired approval for a new drug,’Recrajajung’, a lung cancer treatment by Yuhan Corporation

Acquired approval for a new drug,’Recrajajung’, a lung cancer treatment by Yuhan Corporation

The 31st domestic new drug Yuhan Corporation’s anticancer drug’Lecra Jajeong’ license

The 31st domestic new drug Yuhan Corporation’s anticancer drug’Lecra Jajeong’ license

The 31st domestic new drug Yuhan Corporation’s anticancer drug’Lecra Jajeong’ license

The 31st domestic new drug Yuhan Corporation’s anticancer drug’Lecra Jajeong’ license

Licensed in Korea as a new drug for Lung Cancer by Yuhan Corporation.

Licensed in Korea as a new drug for Lung Cancer by Yuhan Corporation.

Will Yuhan Corporation’Lasertinib’ conditional permission come out? Trademark registration

Will Yuhan Corporation’Lasertinib’ conditional permission come out? Trademark registration

Second Moder or Corona 19 vaccine after Pfizer is also approved… What about Moder or related stocks Celltrion, kpx Life Science, Shinpoong Pharmaceutical, Woori Bio, and Yuhan Corporation?

Second Moder or Corona 19 vaccine after Pfizer is also approved… What about Moder or related stocks Celltrion, kpx Life Science, Shinpoong Pharmaceutical, Woori Bio, and Yuhan Corporation?

Newer posts

← Previous Page1 Page2 Page3

footer

Contact Us
Sitemap
News-Sitemap

© 2025 Aju.News/en